MedTrace Logo

Penthrox in Rezūm BPH

NCT04029012 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-01-24

No results posted yet for this study

Summary

Open-labeled, single-centre study

Conditions

Interventions

DRUG

Methoxyflurane

Methoxyflurane inhaler before Rezum procedure

Sponsors & Collaborators

  • Dean Elterman

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2020-02-14
Completion
2020-02-14

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04029012 on ClinicalTrials.gov